The effect of the calcium channel blocking agent, verapamil, on microcirculatory patterns and hepatic function was investigated in the perfused liver of cirrhotic rats. Compared with controls, cirrhotic livers had higher vascular resistance, increased intrahepatic shunting, and smaller extravascular albumin space and larger extravascular sucrose space, as determined by a multipleindicator dilution technique. Hepatic function, estimated by determining propranolol and antipyrine extraction, was markedly reduced in cirrhotic livers. Portal pressure was then reduced 25% either pharmacologically by verapamil or hydrodynamically by lowering inflow. Verapamil decreased vascular resistance by 22%. This was associated with a 38% reduction in intrahepatic shunting and a 62% increase in extravascular albumin space. Hydrodynamically lowering pressure had no or adverse effects. The verapamil-induced improvement in microcirculatory characteristics was associated with a significant improvement in oxygen consumption (+21%) and antipyrine clearance (+20%). We conclude that the microvascular distortions of liver cirrhosis in the rat are partially reversible by vasodilators like verapamil.
Introduction
Pharmacotherapy of portal hypertension has been limited so far to lowering portal pressure by decreasing splanchnic blood flow, either acutely with vasopressin or somatostatin (1) or chronically with beta blockers such as propranolol (2, 3) . Decreasing perfusion of an organ with already compromised function could lead to a further decrease in function and eventually to decompensation.
An alternative approach, namely lowering pressure by decreasing hepatic resistance, has not yet been systematically explored. It is unknown to what degree, ifany, portal hypertension and microvascular alterations of cirrhosis, such as intrahepatic shunting and sinusoidal capillarization (4) (5) (6) (7) , are reversible. This approach appears promising, however, because one would expect maintenance or even improvement of hepatic function when hepatic blood flow is maintained.
We therefore investigated the effect of a calcium channel blocker, verapamil, on hepatic microcirculation and function in the perfused liver of cirrhotic rats. We have investigated ver- This study has been presented in part at the 1984 meeting ofthe AASLD and was published as an abstract (1984 ( . Hepatology. 4:1027 .
Received for publication I July 1985 and in revised form 7 April 1986. apamil because (a) it has a high first-pass effect (8) , (b) calcium channel blockers affect all smooth muscle cells examined (9) , and (c) verapamil has been shown to increase estimated hepatic blood flow in humans (10) . Verapamil administered intravenously has recently been shown to reduce wedged hepatic vein pressure in humans (1 1). Finally, we have presented preliminary evidence that the drug improves indocyanine green clearance in patients with liver cirrhosis (12 were prepared by incubating 1 ml of human erythrocytes with 0.1 mCi of Na-51Cr2O4 (New England Nuclear). '25I-albumin was prepared by the lactate peroxidase method. Free iodine was removed by chromatography on a 10-ml Sephadex G-100 column and by dialysis overnight against phosphate-buffered saline. The final product had a specific activity of 1,200 cpm/Ag protein and was >95% precipitable by trichloroacetic acid. Verapamil HCl was obtained commercially in injectable form. Induction ofcirrhosis. Cirrhosis was induced in rats, weighing 125-150 g at the start ofthe study, by chronic exposure to phenobarbital and carbon tetrachloride according to McLean et al. (13) . Treatment was ceased at least 2 wk prior to the study. Control animals were kept under identical conditions but exposed to neither toxin. Treated rats gained less weight than control rats, their weights at the time ofstudy averaging 464±48 and 486±59 g, respectively. The corresponding liver weights were 20.6±3.5 and 18.7±2.0 g. All animals had cirrhosis by gross inspection and histologic examination. 73% ofthe animals had ascites (>2 ml) at the time of study.
Rat liver perfusion. Animals were anesthetized with pentobarbital 50 mg/kg intraperitoneally and were heparinized (1,000 IU/kg) prior to cannulation of the portal vein. Portal pressure was measured in vivo by cannulating the ileocolic vein with PE 50 tubing (Clay-Adams, Parsipanny, NJ). Portal perfusion was then performed as previously described in detail (14, 15) . A semisynthetic medium consisting of washed human erythrocytes (20% vol/vol), bovine serum albumin (2% wt/vol), and dextrose (0.1% wt/vol) in Krebs-Ringer bicarbonate buffer was used. Portal perfusing pressure was set at the value measured in vivo using a constriction valve in the portal inflow (see Fig. 1 ). The perfusion system employed a hydrostatic head with a constricting valve (No. 2 in Fig. 1 ) permitting regulation ofinflow. This setup permits detection ofalterations in pressure by the in-line hydrostatic manometer (No. 3 in Fig. 1 ( 18) .
In a first set of experiments (n = 6 cirrhotics and controls each), verapamil hydrochloride was added to the reservoir in 5-mg increments until portal pressure had been reduced by 25% in cirrhotic animals. Control livers were paired with a cirrhotic liver and received an equal amount of verapamil as the cirrhotic liver regardless of its pharmacodynamic effects in the normal liver. After 10 min of perfusion at the reduced pressure, all measures of viability were repeated. Then, the multiple indicator dilution experiments, shunt fraction, and propranolol and antipyrine extraction measurements were repeated.
To control for potential effects of changes in flow on the different measures ofhepatic microcirculation, the effects of mechanically lowering portal pressure were assessed in a second set of five control and cirrhotic rats each. The experimental design was similar: during a control period, all measurements of hepatic microcirculation, function and viability were assessed. Then pressure was lowered by 25% by closing the valve in the portal inflow (see Fig. 1 ). After a 10-min adaptation period, all the measures described above were repeated.
Data analysis. The indicator dilution curves were expressed as frequency functions [h(t)], and mean transit times were calculated according to classical indicator dilution theory ( 19) . Vascular space was calculated as the product of flow and tRBc; extravascular albumin space (EVA) was calculated as EVA = PF(tMb -tRBC), where t^b and tRw are the mean transit times for albumin and erythrocytes, respectively, and PF is plasma flow (19, 20) . The extravascular albumin space thus is model-independent. Extravascular sucrose space was calculated in an analogous fashion, substituting t sucrose for tArb.
Clearance was calculated as the product offlow determined volumetrically and extraction (21) . Means were compared by Student's t test; effects of different treatments within animals were compared with Student's paired t test (22). Linear regression analysis was performed by the method of least squares (22). P < 0.05 was considered statistically significant.
Results
During the control period, cirrhotic livers exhibited significantly higher portal resistance and lower liver blood flow expressed on a per gram liver basis than control rats (Table I ). Oxygen consumption was significantly lower in cirrhotic livers (P < 0.001; Table I ). In contrast, neither aspartate aminotransferase nor potassium release into the perfusion medium differed significantly between the groups (Table I) .
15-30 mg ofverapamil were required to lower portal pressure by 25%; taking the volume of the perfusate into account, verapamil concentrations of 8-16 mg/I00 ml can be calculated. Verapamil administration resulted in a 22% reduction in hepatic resistance without significant changes in hepatic perfusion in cirrhotic livers. In control livers, portal pressure was reduced by 14% only; neither flow nor resistance was significantly affected (Table II) . In contrast, mechanically lowering portal pressure by a similar amount significantly increased hepatic resistance and consequently resulted in decreased hepatic perfusion in both control and cirrhotic livers (Table II) .
Neither verapamil nor mechanical lowering ofportal pressure affected viability of the perfused organ as assessed by aspartate aminotransferase or potassium release. Oxygen consumption in control livers did not change after verapamil administration (2.24±0.08 vs. 2.14±0.14 smol -min' -g liver-'; NS) but decreased from 2.28±0.17 to 2.05±0.10 MAmol -min-' * g liver-' (P < 0.025) after mechanically lowering portal pressure. In cirrhotic livers, a similar, although statistically not significant decrease (from 1.78±0.15 to 1.44±0.20; NS) was seen, whereas verapamil significantly increased oxygen consumption from 1.55±0.24 to 1.88±0. 18 Mmol -min-' *g liver-' (P < 0.02).
Intrahepatic shunting averaged 0.10±0.1 1% in control livers; neither pharmacological nor mechanical lowering of portal pressure altered the shunt fraction. Intrahepatic shunting in cirrhotic livers averaged 3.80±2.85% (P < 0.005 compared to con- (Fig. 3) . Thus, the albumin curve was almost superimposed upon the erythrocyte curve whereas the sucrose curve increasingly diverged from its associated albumin curve, a pattern suggestive of sinusoidal capillarization (6, 23) . The erythrocyte space was significantly smaller in cirrhotic livers, averaging 0.148±0.020 ml/g (P < 0.01). Similarly, the extravascular albumin space was reduced to 0.026±0.013 ml/g (P < 0.001) whereas the extravascular sucrose space was actually increased to 0.184±0.024 ml/g (P < 0.001).
The effects of the different treatments on erythrocyte, albumin, and sucrose space in control and cirrhotic livers are summarized in Table III (Table III) . This effect is also illustrated in Figs. 4 and 5, which demonstrate improved exchange ofalbumin with the extravascular space after verapamil administration. Fig. 5 demonstrates that this effect was due to verapamil and not to decreased pressure and/or flow, in that the extravascular albumin space decreased after mechanical lowering in both control and cirrhotic livers. Propranolol extraction in controls averaged 97.7±1.9%; it was significantly reduced in cirrhotics, averaging only 71.3±11.2% (P < 0.001). Similarly, single-pass extraction of antipyrine was markedly reduced, averaging 22.4±1.7% and 4.6±1.2% in control and cirrhotic livers, respectively (P < 0.001). The effects of the different treatments on drug extraction are summarized in Table IV . Verapamil significantly improved antipyrine but not propranolol extraction in cirrhotics. (Table IV) . The effects of lowering portal pressure on drug extraction are shown graphically in Fig. 6 .
When clearance was calculated as the product offlow (Table  I ) and drug extraction (Table IV) , marked differences were apparent again. Thus, antipyrine clearance averaged 0.332±0.069 and 0.046±0.018 ml-min-' g-' (P < 0.001) in controls and cirrhotics, respectively. The corresponding propranolol clearances were 1.45±0.28 and 0.70±0.19 ml min' g-' (P< 0.001). Antipyrine and propranolol clearance correlated significantly in both control (r = 0.938; P < 0.001) and cirrhotic (r = 0.679; P < 0.05) rats, but the two regression lines differed obviously (Fig.  7) . Because mechanically lowering the portal pressure had effects on blood flow that were different from those ofverapamil (Table°c \ Cirrhosis + !^V erapamil II), the effects of the two manipulations on drug clearance were more marked than those on drug extraction. Mechanically lowering portal pressure decreased the clearance of both drugs in control as well as in cirrhotic livers, whereas verapamil had no effect in control livers (Table V) . In cirrhotic livers, by contrast, verapamil significantly improved antipyrine, but not propranolol clearance (Table V) .
Neither shunted fraction, portal pressure, portal flow, nor hepatic resistance correlated with either drug clearance (data not shown). By contrast, both antipyrine (Fig. 8) Fig. 10 . Portal hypertension, as measured in vivo, was observed in all cirrhotic animals. The merits and deficiencies of the phenobarbital/carbon tetrachloride model (13) have recently been reviewed (24) . Hemodynamically, our cirrhotic livers were characterized by increased portal resistance resulting in decreased portal flow when perfused at the portal pressure determined in vivo (Table 1 ). In this respect our results are comparable to the study by Varin and Huet (23) who used the same model of cirrhosis induction but at variance with in vivo studies by Vorobioffet al. (25) . The latter difference is most likely due to the more advanced nature of the lesion in our study; thus in the present study portal pressure averaged 15.8 cmH20, as compared with 13.5 cmH20 in Vorobioffs study, and 73% of our animals as compared with 50% of theirs had ascites. Anatomic intrahepatic shunts, defined as the fraction of 15-,um microspheres passing through the liver, was quantitatively not very important, averaging only 3.8% (range 0.9-10%). This figure is in the range of those published for the perfused liver (23) but lower than that reported from several in vivo studies (25, 26) .
Multiple-indicator dilution studies showed a transition from the usual, flow-limited behavior of albumin and sucrose to diffusion-limited exchange (27) . This can be qualitatively inferred from the shape of the indicator dilution curves: flow-limited exchange has been postulated by Goresky (20, 27) to result in a smooth decay of intra-and extravascular reference substances, the latter being reduced in magnitude (by a factor depending on the ratio of intra/extravascular volume of distribution) and delayed (by time spent in large, nonexchanging vessels). Diffusionlimited exchange, by contrast, occurs in tight capillaries such as those ofthe myocardium (27) . It is characterized bythe albumin curve's being almost superimposed upon the erythrocyte curve and by diffusible reference substances, such as sucrose, that show a deviation from the behavior predicted from the albumin curve owing to diffusion across the endothelial barrier (27) . This results in a biphasic curve, the first part representing material that has not left the intravascular plasma space, and the second one material returning from the extravascular sucrose space (27) .
Similar distortions of multiple indicator dilution curves in humans and rats have been ascribed to sinusoidal capillarization (6, 23) . Such capillarization has been demonstrated by trans- mission electron microscopy (4, 5) and basement membranelike deposits have been demonstrated immunohistochemically (28, 29) . The functional significance of these changes in cirrhosis have first been appreciated by Huet and colleagues (6, 23) , who demonstrated a close correlation between changes in function and sinusoidal capillarization. We found a similar correlation between the clearance of both a high (propranolol, Fig. 9 ) and a low (antipyrine, Fig. 8 ) extraction compound and extravascular albumin space. No other parameter of deranged hepatic hemodynamics (flow, resistance, portal pressure, intrahepatic shunting) correlated with function in our study. The decrease in extravascular albumin space is comparable to that described by Varin and Huet (23) ; similarly, the increase in extravascular sucrose space is comparable to values reported in the literature. This increase in sucrose space has been ascribed tentatively to the ability of sucrose to permeate into fibrous tissue in the extravascular space (23) .
Hepatic function was markedly reduced measured by the clearance ofboth, a low and a high extraction compound, namely antipyrine and propranolol, respectively. This is in accordance with findings in humans (30-32) and rats (26, 33) . Presumably, the reduced oxygen consumption is also an expression of decreased function rather than of compromised viability of the organ. Viability of perfused cirrhotic livers was comparable to control livers when transaminase and potassium release are con- sidered (Table I) . Reduced oxygen consumption was reported in a similar study in the rat (23) and demonstrated in end-stage cirrhosis in humans (34). We have recently described reduced oxygen consumption in hepatocytes isolated from cirrhotic livers where hemodynamic alterations are excluded (35) . Verapamil significantly reduced portal pressure by reducing portal vascular resistance, leaving portal flow unaffected (Table  II) . This apparent paradox is easily explained by assuming perfusion of sinusoids with different physical characteristics (see Fig. 10 ). Verapamil could exert these effects by acting on endothelial cells, the main determinants of sinusoidal perfusion (36, 37) . Verapamil is known to affect all smooth muscle cells (9) , including those of rat portal vein (38) ; it is unknown, however, whether verapamil affects hepatic endothelial cells. The verapamil concentrations achieved in our experiments can be calculated to be 8-16 mg/100 ml or 200-400 umol/liter. This is well above the concentration where verapamil changes from a specific calcium antagonist to a sodium channel blocker (39) . Thus, we cannot exclude that nonspecific membrane effects of verapamil were contributing to our results.
Inspecting the effects of verapamil on the indicator dilution curves (Fig. 4) , it appears unlikely that these effects were achieved by regulation oflarge vessels. Similarly, an alteration ofsinusoidal capillarization in a given sinusoid appears rather unlikely, inasmuch as this consists offormation ofa basement membranelike structure occluding the fenestrations in the sinusoidal lining cells (4) (5) (6) . Another possibility is that verapamil alters the size and/ or number of endothelial fenestrations. Whether dynamic alteration of these important determinants of transsinusoidal exchange occurs is unknown. They are known, however, to be altered in response to increased portal pressure in the rat (40) and in alcohol-induced chronic liver injury in baboons (41) . Considering the nature of capillarization (4) (5) (6) , however, such a mechanism appears rather unlikely also. Again, the mechanism invoked to explain the altered hemodynamics after verapamil administration, namely perfusion of sinusoids with different physical characteristics (Fig. 10) , appears most apt to explain the observed changes in sinusoidal extravascular space. The per-fusion of sinusoids with different accessibility of albumin to the extravascular space could also explain the observed improvement in oxygen consumption and antipyrine clearance.
A similar mechanism can be invoked to explain the decrease in extravascular albumin space, impaired oxygen consumption, and decreased antipyrine clearance observed after hydrodynamic lowering of portal pressure: a decrease in pressure could lead to partial collapse of sinusoids with relatively well-maintained exchange characteristics (Fig. 10) . Such an explanation could also explain the failure of extraction to increase when flow decreases as predicted from theoretical considerations (21) . The effects achieved with verapamil and hydrodynamic alterations of portal pressure differ from increasing pressure pharmacologically with norepinephrine (42) or hydrodynamically by venous outflow obstruction (43) . Increasing the pressure leads to alteration of vascular, but not extravascular volumes in normal liver (42) . We ascribe these effects to the mechanisms invoked in Fig. 10 (46, 47) and is independent of liver blood flow (48). Thus, it is conceivable that, in measuring singlepass uptake of propranolol, we measured the passive distribution phenomena only, and that prolonged observation of the fate of propranolol would reveal effects similar to those achieved for antipyrine. Alternatively, the different effects could be due to different protein binding, antipyrine being much less extensively bound (46) (53) . In patients with more advanced liver disease, propranolol has not been effective (54) . This could be due to increased hepatic vascular resistance (55) and/or reduced sensitivity to norepinephrine in the splanchnic vascular bed maintaining high flow against an unchanged hepatic resistance (56) . In our model, propranolol even at very high doses up to 200 mg, had no effect on any of the parameters measured (J. Reichen, unpublished observations); this is in agreement with data obtained in the intact animal (55) .
In conclusion, we (12) are encouraging.
